Skip to content
healthcare.dev

NIPRIDE RTU

NDC 51754-1006, Sodium Nitroprusside, injection, solution, from EXELA PHARMA SCIENCES, LLC.

Product NDC
51754-1006
Status
Listed
Labeler
EXELA PHARMA SCIENCES, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209387
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51754-1006 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SODIUM NITROPRUSSIDE.5 mg/mL

Pharmacologic classes

Vasodilation [PE]; Vasodilator [EPC]

Package NDCNDC-11Package
51754-1006-1517541006011 VIAL in 1 VIAL (51754-1006-1) / 100 mL in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5acf0836-93ff-4064-b888-3f560e8a558d

Use it

Look up 51754-1006 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51754-1006 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51754-1006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.